@misc{indiciae4427d0006005,
  title = {Discovery and evaluation of novel biomarkers reveal dasatinib as a potential treatment for a specific subtype of Triple-Negative Breast Cancer},
  author = {Ortega-Alvarez, D. and Tebar-Garcia, D. and Casado-Pelaez, M. and Castillo-Agea, E. and Balibrea-Rull, J. and Olivares-Osuna, D. and Perez-Parra, D. and Guardia, C. and Musulen, E. and Vinuesa-Pitarch, E. and Sanchez-Lopez, E. and Postigo-Corrales, F. and Ballana, E. and Martinez-Cardus, A. and Margeli, M. and Esteller, M. and Fernandez-Ruiz, P. L. and Luengo-Gil, G. and Mereu, E. and Galan-Moya, E. M. and Rodilla, V.},
  year = {2024},
  doi = {10.1101/2024.07.24.603752},
  url = {https://www.biorxiv.org/content/10.1101/2024.07.24.603752v1},
  note = {Source identifier: 10.1101/2024.07.24.603752}
}